pharmaceutical companies

They hire marketing agencies, who take into account all sorts of legal, regulatory, and psychological factors.

After years of wide-open compounding, regulators say they’re ready to enforce limits and restore control over the fast-growing GLP-1 market.

Under the Trump administration, the government has rescinded research funding, changed vaccine recommendations, and refused to review Moderna’s new mRNA flu vaccine. That could set vaccine research and development back for years.

But drug companies are trying to stymie the effort with a raft of lawsuits.

Some offer patient assistance programs, where people can access drugs for free, or cheaper than they would normally pay.

Advocates say a waiver is “a moral imperative” to help make vaccines readily available worldwide.

The question is: Are they really necessary?

The president is expected to meet with pharmaceutical industry executives, who are opposed to the changes, on Tuesday.

Incarcerated people form a large market for pharmaceutical companies. The ethics of that relationship can be complicated.

The nation’s three dominant drug distributors and a big drugmaker have reached a $260 million deal to settle an opioid crisis lawsuit just as the first federal trial over the crisis was due to begin.